All News #Library
Rare Diseases
FDA Chief Says He’s Open To Rethinking Incentives On Orphan Drugs
22 Dec 2017 //
KHN
The Cost of Drugs for Rare Diseases Is Threatening the U.S. Health Care System
10 Apr 2017 //
HARVARD BUSINESS REVIEW
Sky-High Drug Prices For Rare Diseases Show Why Orphan Drug Act Needs Reform
18 Mar 2017 //
HUFFINGTON POST

Market Place
Sourcing Support